The Heterochromatin protein 1 is a master regulator in RNA splicing precision deficient in ulcerative colitis
J. Mata -Garrido, Y. Xiang, Y. Chang-Marchand, C. Reisacher, E. Ageron-ardila, C. Guerrera, I. Casafont, A. Bruneau, C. Cherbuy, X. Treton, A. Dumay, E. Ogier-Denis, E. Batsche, M. Costallat, G. Revechon, M. Eriksson, C. Muchardt, L. Arbibe
Abstract
Defects in RNA splicing have been linked to numerous human disorders, but remain poorly explored in inflammatory bowel disease (IBD). Here, we report that, in the gut epithelium of patients with ulcerative colitis (UC), the expression of the chromatin and alternative splicing regulator HP1{gamma} is strongly reduced. Accordingly, inactivation of the HP1{gamma} gene in the mouse gut triggered several IBD-like traits, including inflammation and dysbiosis. In parallel, we discovered that its loss of function broadly increased splicing noise, reducing requirement for canonical splicing consensus sequences, and favoring the usage of cryptic splice sites at numerous genes with key functions in gut biology. This notably resulted in the production of progerin, a noncanonical toxic splice variant of prelamin A mRNA, responsible for the Hutchinson Gilford Progeria Syndrome (HGPS) of premature aging. Likewise, production of progerin transcript was found to be a signature of colonic cells from UC patients. Thus, our study identifies HP1{gamma} as a regulator of RNA metabolism in vivo, providing a unique mechanism linking anti-inflammation and accuracy of RNA splicing in the gut epithelium. HP1 defect may confer a general disturbance in RNA splicing precision to scrutinize in IBD and more generally in accelerating aging diseases.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HP1γ binding pre-mRNA at intronic repeats increases splicing fidelity and regulates alternative exon usage.
Christophe Rachez, Rachel Legendre, … Christian Muchardt·bioRxiv·Oct 23, 2019
- An image-based CRISPR screen reveals splicing-mediated control of HP1α condensates
Matthew Man-Kin Wong, Shaopu Zhou, … Serena Sanulli·bioRxiv·Sep 21, 2025
- Transcriptome-wide Differential Expression and Splicing in Inflammatory Bowel Disease Patients
Shuying Han, Yu‐Chen Huang, … Terrence S. Furey·bioRxiv·Oct 27, 2026
- RNA-coupled CRISPR Screens Reveal ZNF207 as a Regulator of LMNA Aberrant Splicing in Progeria
Amit K. Behera, Jeongjin J. Kim, … Thomas Gonatopoulos-Pournatzis·Molecular CellPeer-reviewed·Dec 30, 2025
- The HP1γ epigenetic silencer dampens IFN-γ response at the gut epithelial barrier
Y. Chang, J. Mata-Garrido, … Y. C. Marchand·bioRxiv·Dec 27, 2022
- Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease
I. Fraschilla, H. Amatullah, … K. Jeffrey·bioRxiv·Mar 29, 2022